top of page

Annovis Bio Founder & CEO Maria Maccecchini shares an update on the oral small molecule buntanetap, which is currently in a pivotal trial for Alzheimer's

  • Feb 2
  • 1 min read

She describes the mechanism of the drug, which she says is capable of inhibiting multiple types of diseases proteins in the brain. Plus, an update on the enrollment and timeline of the company's phase three study that is ongoing.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page